Format

Send to

Choose Destination
Dig Dis Sci. 2001 Aug;46(8):1787-90.

Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.

Author information

1
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. Schwartz.David@Mayo.edu

Abstract

Patients with eosinophilic gastroenteritis generally respond well to corticosteroids but relapses are common. Patients with relapsing disease are usually placed on long-term low-dose prednisone or immunosuppressive therapy. Here we reported on a patient with severe steroid-dependent eosinophilic gastroenteritis who was able to successfully taper off steroids and maintain remission after starting montelukast, a leukotriene receptor antagonist. To our knowledge, this is the first use of montelukast as a steroid sparing agent for eosinophilic gastroenteritis.

PMID:
11508684
DOI:
10.1023/a:1010682310928
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center